We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.71%
2 Healthcare 16.11%
3 Consumer Discretionary 15.3%
4 Communication Services 13.46%
5 Financials 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1251
Williams-Sonoma
WSM
$28.6B
$24.3M ﹤0.01%
305,014
+58,594
+24% +$4.99M
ALRM icon
1252
Alarm.com
ALRM
$2.71B
$24.2M ﹤0.01%
286,003
+3,276
+1% +$280K
PHM icon
1253
Pultegroup
PHM
$24.7B
$24.2M ﹤0.01%
443,300
+5,548
+1% +$310K
UTMD icon
1254
Utah Medical Products
UTMD
$229M
$23.9M ﹤0.01%
281,630
+1,735
+0.6% +$150K
FBNC icon
1255
First Bancorp
FBNC
$2.75B
$23.8M ﹤0.01%
581,592
-26,005
-4% -$1.12M
BHP icon
1256
BHP
BHP
$222B
$23.8M ﹤0.01%
365,824
+59,123
+19% +$3.91M
ABCM
1257
DELISTED
Abcam PLC
ABCM
$23.7M ﹤0.01%
1,247,299
+19,667
+2% +$392K
JBSS icon
1258
John B. Sanfilippo & Son
JBSS
$1.01B
$23.5M ﹤0.01%
265,650
+310
+0.1% +$28.2K
SMAR
1259
DELISTED
Smartsheet Inc.
SMAR
$23.5M ﹤0.01%
324,929
+60,524
+23% +$3.78M
BL icon
1260
BlackLine
BL
$1.75B
$23.5M ﹤0.01%
210,774
-26,564
-11% -$2.9M
SANA icon
1261
Sana Biotechnology
SANA
$1.04B
$23.4M ﹤0.01%
1,190,199
-16,511
-1% -$374K
MAS icon
1262
Masco
MAS
$14.6B
$23.4M ﹤0.01%
396,796
-27,690
-7% -$1.71M
OGN icon
1263
Organon & Co
OGN
$3.6B
$23.1M ﹤0.01%
+764,241
New +$25.2M
PBR icon
1264
Petrobras
PBR
$116B
$23M ﹤0.01%
1,882,603
-148,700
-7% -$1.46M
UDR icon
1265
UDR
UDR
$12.2B
$23M ﹤0.01%
469,533
-6,690
-1% -$315K
TTI icon
1266
TETRA Technologies
TTI
$1.27B
$22.8M ﹤0.01%
5,248,170
+57,976
+1% +$191K
LKQ icon
1267
LKQ Corp
LKQ
$6.43B
$22.8M ﹤0.01%
462,665
-10,870
-2% -$519K
PCRX icon
1268
Pacira BioSciences
PCRX
$928M
$22.7M ﹤0.01%
373,652
+9,689
+3% +$613K
PAAS icon
1269
Pan American Silver
PAAS
$20.2B
$22.7M ﹤0.01%
+793,191
New +$25.6M
IRM icon
1270
Iron Mountain
IRM
$37.8B
$22.5M ﹤0.01%
530,731
-12,090
-2% -$507K
SJM icon
1271
J.M. Smucker
SJM
$12.9B
$22.4M ﹤0.01%
172,892
-6,700
-4% -$890K
SAFT icon
1272
Safety Insurance
SAFT
$1.52B
$22.4M ﹤0.01%
286,003
-476,289
-62% -$39.7M
CMIIU
1273
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$22.3M ﹤0.01%
1,658,794
-44,506
-3% -$593K
STRT icon
1274
STRATTEC Security
STRT
$342M
$22.2M ﹤0.01%
500,069
-563
-0.1% -$26.9K
LNT icon
1275
Alliant Energy
LNT
$18.2B
$22.2M ﹤0.01%
398,407
-2,490
-0.6% -$141K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.